Abstract:Objective This study aimed to examine the impact of maternal obesity on fetal growth abnormalities including fetal growth restriction (FGR) and large for gestational age (LGA) fetuses. Study Design Secondary analysis from the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (nuMoM2b). The study excluded individuals with pregestational or gestational diabetes, chronic hypertension, and other major maternal medical conditions. First-trimester ultrasound was performed to establish accurate dating criteria. Ultrasound assessments were performed at 16 to 21 and 22 to 29 weeks of gestation. Our exposure was the presence of pre-pregnancy obesity. Our primary outcome was rates of fetal growth abnormalities identified by ultrasound, defined as FGR (estimated fetal weight [EFW] or abdominal circumference 90th percentile) among obese compared with nonobese women. A secondary analysis was performed after limiting ultrasound performed from 28 to 29 weeks. To estimate adjusted relative risks (aRRs) with 95% confidence intervals (95% CIs), we used generalized linear models with Poisson distribution and log link using robust error variance, adjusting for the predefined covariates. Results Of 7,354 participants, 1,443 (19.6%) had pre-pregnancy obesity while 5,911 (80.4%) did not. Pre-pregnancy obesity compared with normal weight was associated with an increased risk of fetal growth abnormalities both at 16 to 21 weeks (16.0% vs. 13.2%; aRR 1.23; 95% CI 1.06–1.42) and 22 to 29 weeks (16.0% vs. 12.1%; aRR 1.33; 95% CI 1.14–1.54). Furthermore, pre-pregnancy obesity compared with normal weight was associated with an increased risk of LGA both at 16 to 21 weeks (12.5% vs. 10.3%; aRR 1.24; 95% CI 1.05–1.47) and 22 to 29 weeks (10.6% vs. 6.9%; aRR 1.66; 95% CI 1.38–2.01). In a secondary analysis limited to the ultrasound at 28 to 29 weeks, both fetal growth abnormalities and LGA were associated with the presence of obesity. In any of the analyses, pre-pregnancy obesity was not associated with FGR compared with normal weight. Conclusion Maternal obesity is associated with an increased risk of fetal growth abnormalities and LGA fetuses. Key Points Obesity is associated with increased LGA risk. Association between obesity and FGR remains unclear. Ultrasound is effective in obese women to detect fetal growth abnormalities. Future research is needed to assess the association between obesity and FGR. Received: 18 July 2024 Accepted: 03 November 2024 Accepted Manuscript online: 04 November 2024 Article published online: 25 November 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Placental pathology and fetal growth outcomes in pregnancies complicated by maternal obesity

Effects of Placental Shape on Perinatal Outcome

Placental dysfunction in obese women and antenatal surveillance

Maternal Prepregnancy Obesity is Associated with Higher Risk of Placental Pathological Lesions.

Human Placental Adaptive Changes in Response to Maternal Obesity: Sex Specificities

Placental inflammation, oxidative stress, and fetal outcomes in maternal obesity

Maternal Pre-Pregnancy Obesity Is Associated with Altered Placental Transcriptome

Modulation of Fatty Acid Transport and Metabolism by Maternal Obesity in the Human Full-Term Placenta1

Maternal obesity and placental function: impaired maternal–fetal axis

Effects of maternal obesity on placental function and fetal development

Gestational Age, Infection, and Suboptimal Maternal Prepregnancy BMI Independently Associate with Placental Histopathology in a Cohort of Pregnancies without Major Maternal Comorbidities

The Impact of Increasing Obesity Class on Obstetrical Outcomes.

The Impact of Maternal Body Composition and Dietary Fat Consumption upon Placental Lipid Processing and Offspring Metabolic Health

The Effects of Maternal Obesity on Porcine Placental Efficiency and Proteome

Placental Pathologic Features In Macrosomia

Decreased Fatty Acid Transporter FABP1 and Increased Isoprostanes and Neuroprostanes in the Human Term Placenta: Implications for Inflammation and Birth Weight in Maternal Pre-Gestational Obesity

Impact of Obesity and Hyperglycemia on Placental Mitochondria

Effects of Paternal Obesity on Fetal Development and Pregnancy Complications: A Prospective Clinical Cohort Study

Influence of maternal body mass index on pregnancy complications and outcomes: a systematic review and meta-analysis

Associations between placental pathology and poor intrauterine growth among a cohort of mother-infant singleton pairs in Leyte, the Philippines

Fetal Growth Ultrasound in Obese Patients for the Detection of Growth Abnormalities